![Bart Cornelissen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 901 668 $ al 31/05/2026
Bart Cornelissen currently works at Xencor, Inc., as Chief Financial Officer & Senior Vice President from 2024.
Mr. Cornelissen also formerly worked at Seagen, Inc., as Vice President-Finance.
Mr. Cornelissen received his graduate degree from Rotterdam School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
XENCOR, INC. 0,1 % | 10/04/2026 | 75.898 ( 0,1 % ) | 901 668 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| XENCOR, INC. | Director Financiero/CFO | 09/04/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| SEAGEN INC. | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Rotterdam School of Management
 Rotterdam School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
